Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04797559 · ClinicalTrials.gov registry record · NA
SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04797559: Completed NA study, sponsored by Stanford University.
NCT04797559 is a NA study that has completed, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04797559, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures, however, have not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goals of this study are to determine if SZMN block can be utilized for pain control and decrease morbidity in pediatric patients undergoing T\&A.
Interventions
- PROCEDURE SZMN Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2023-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04797559
The ClinicalTrials.gov registry entry for NCT04797559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SZMN Block is the first listed.
NCT04797559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04797559 about?
NCT04797559 is a clinical study titled "SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A". The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures, however, have not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goals of this study are to...
What is the current status of trial NCT04797559?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-11-29. Estimated completion is 2023-04-19.
What interventions are being tested in trial NCT04797559?
The interventions under investigation include: SZMN Block (PROCEDURE).
Who is sponsoring clinical trial NCT04797559?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.